Group One Trading
TRAW icon

Group One Trading’s Traws Pharma TRAW Stock Holding History

Group One Trading’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,000
Closed -$178K – 8505
2024
Q4 		$178K Buy
+20,000
New +$111K ﹤0.01% 4039
2024
Q1 		– Sell
-20
Closed -$373 – 8107
2023
Q4 		$373 Sell
20
-236
-92% -$4.01K ﹤0.01% 7119
2023
Q3 		$4.62K Sell
256
-464
-64% -$10.6K ﹤0.01% 6734
2023
Q2 		$21.2K Buy
720
+644
+847% +$17.3K ﹤0.01% 5958
2023
Q1 		$1.39K Buy
76
+64
+533% +$1.39K ﹤0.01% 6701
2022
Q4 		$193 Sell
12
-12
-50% -$226 ﹤0.01% 7037
2022
Q3 		$1K Hold
24
– – ﹤0.01% 7396
2022
Q2 		$1K Sell
24
-200
-89% -$6.75K ﹤0.01% 7646
2022
Q1 		$10K Sell
224
-36
-14% -$1.67K ﹤0.01% 7177
2021
Q4 		$17K Buy
+260
New +$20.9K ﹤0.01% 7081
2015
Q4 		– Hold
0
– -$3K – 5159
2015
Q3 		– Hold
0
– – – 4639
2015
Q1 		– Hold
0
– -$1K – 5275
2014
Q4 		– Hold
0
– – – 4786
2014
Q3 		– Hold
0
– – – 4800
2014
Q2 		– Hold
0
– – – 4774
2014
Q1 		– Hold
0
– – – 4938

Other funds holding TRAW

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Group One Trading's TRAW Position: Q1 2025 in Review

Group One Trading sold out of Traws Pharma (TRAW) in Q1 2025, closing a stake of 1,164 shares — an estimated $10.3K sold.

Group One Trading first reported a position in TRAW in Q3 2021 and held it in 14 quarters. The position peaked at $23K in Q3 2021. 19 funds tracked by Wall St. Rank hold TRAW as of Q1 2025.

  • Group One Trading reported no remaining Traws Pharma position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 1,164 Traws Pharma shares in Q1 2025, an estimated $10.3K.
  • Group One Trading first reported a position in Traws Pharma in Q3 2021 and held it in 14 quarters.
  • Group One Trading's Traws Pharma position peaked at $23K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.